Literature DB >> 10981786

A measure of handicap for low vision rehabilitation: the impact of vision impairment profile.

J B Hassell1, L M Weih, J E Keeffe.   

Abstract

This study aims to further develop the Impact of Vision Impairment (IVI) profile into a practical, valid instrument for use in low vision rehabilitation. The IVI item pool was derived from focus groups of people with impaired vision, relevant content of existing quality of life questionnaires, and the administration of two trial versions. The second trial version of IVI was administered to 256 people who were vision impaired. Items were deleted if they were of little or no concern or were unable to be performed by most people, had moderate to high inter-item correlation, or did not contribute to a factor in the factor analysis. Two items were deleted due to floor and ceiling effects, 11 due to moderate to high inter-item correlation r> or =0.6. None were removed as a result of factor analysis. The first three factors explained 59% of the variance.This reduced version of the IVI, a tool able to determine rehabilitation needs for people who are vision impaired, will now undergo its final validation procedures.

Entities:  

Mesh:

Year:  2000        PMID: 10981786     DOI: 10.1046/j.1442-9071.2000.00312.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  12 in total

Review 1.  Patient-reported outcomes (PRO's) in glaucoma: a systematic review.

Authors:  S Vandenbroeck; S De Geest; T Zeyen; I Stalmans; F Dobbels
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

2.  An enhanced functional ability questionnaire (faVIQ) to measure the impact of rehabilitation services on the visually impaired.

Authors:  James Stuart Wolffsohn; Jonathan Jackson; Olivia Anne Hunt; Charles Cottriall; Jennifer Lindsay; Richard Gilmour; Anne Sinclair; Robert Harper
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 3.  Optical reading aids for children and young people with low vision.

Authors:  Lucy Barker; Rachel Thomas; Gary Rubin; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2015-03-04

4.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

Review 5.  Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments.

Authors:  Jemaima Che Hamzah; Jennifer M Burr; Craig R Ramsay; Augusto Azuara-Blanco; Maria Prior
Journal:  Qual Life Res       Date:  2011-01-04       Impact factor: 4.147

Review 6.  Patient-centred measurement in ophthalmology--a paradigm shift.

Authors:  Konrad Pesudovs
Journal:  BMC Ophthalmol       Date:  2006-06-15       Impact factor: 2.209

7.  Development of the Ultra-Low Vision Visual Functioning Questionnaire (ULV-VFQ).

Authors:  Pamela E Jeter; Collin Rozanski; Robert Massof; Olukemi Adeyemo; Gislin Dagnelie
Journal:  Transl Vis Sci Technol       Date:  2017-05-31       Impact factor: 3.283

8.  Validation of a vision-related activity scale for patients with retinitis pigmentosa.

Authors:  Francisco M Costela; Konrad Pesudovs; Michael A Sandberg; Carol Weigel-DiFranco; Russell L Woods
Journal:  Health Qual Life Outcomes       Date:  2020-06-22       Impact factor: 3.186

9.  Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).

Authors:  Robyn H Guymer; Peter N Dimitrov; Mary Varsamidis; Lyndell L Lim; Paul N Baird; Algis J Vingrys; Luba Robman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Cross-cultural validation of the Functional Vision Questionnaire for Children and Young People (FVQ_CYP) with visual impairment in the Dutch population: challenges and opportunities.

Authors:  Ellen B M Elsman; Valerija Tadić; Carel F W Peeters; Ger H M B van Rens; Jugnoo S Rahi; Ruth M A van Nispen
Journal:  BMC Med Res Methodol       Date:  2019-12-03       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.